UB Paderborn / Katalog / Suche / in CDI

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

The Lancet (British edition), 2014-02, Vol.383 (9915), p.413-423

2014

Volltextzugriff (PDF)

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

Blood, 2010-07, Vol.116 (1), p.113-121

2010

Volltextzugriff (PDF)

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations

British journal of haematology, 2007-10, Vol.139 (2), p.289-296

2007

Volltextzugriff (PDF)

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis

PLoS medicine, 2008-05, Vol.5 (5), p.e97

2008

Volltextzugriff (PDF)

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study)

PLoS medicine, 2006-08, Vol.3 (8), p.e307-e307

2006

Volltextzugriff (PDF)

Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII

Blood, 2006-12, Vol.108 (13), p.4045-4051

2006

Volltextzugriff (PDF)

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Cardiovascular diabetology, 2021-10, Vol.20 (1), p.217-217, Article 217

2021

Volltextzugriff (PDF)

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

JAMA : the journal of the American Medical Association, 2005-02, Vol.293 (6), p.715

2005

Volltextzugriff (PDF)

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases

PloS one, 2020-12, Vol.15 (12), p.e0244231-e0244231

2020

Volltextzugriff (PDF)

Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use

American journal of hematology, 2008-02, Vol.83 (2), p.97-102

2008

Volltextzugriff (PDF)

Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men

Blood, 2010-07, Vol.116 (4), p.529-536

2010

Volltextzugriff (PDF)

Enhancing discharge decision-making through continuous monitoring in an acute admission ward: a randomized controlled trial

Internal and emergency medicine, 2024-06, Vol.19 (4), p.1051-1061

2024

Volltextzugriff (PDF)

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

The American heart journal, 2016-06, Vol.176, p.28-35

2016

Volltextzugriff (PDF)

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men

Blood, 2007-03, Vol.109 (5), p.1998-2000

2007

Volltextzugriff (PDF)

Early cardiopulmonary resuscitation and use of Automated External Defibrillators by laypersons in out-of-hospital cardiac arrest using an SMS alert service

Resuscitation, 2011-10, Vol.82 (10), p.1273-1278

2011

Volltextzugriff (PDF)

Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men

British journal of haematology, 2009-04, Vol.145 (1), p.121-127

2009

Volltextzugriff (PDF)

Alcohol consumption is associated with a decreased risk of venous thrombosis

Thrombosis and haemostasis, 2008-01, Vol.99 (1), p.59-63

2008

Volltextzugriff (PDF)

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

Catheterization and cardiovascular interventions, 2020-08, Vol.96 (2), p.E110-E118

2020

Volltextzugriff (PDF)

Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial

The American heart journal, 2018-04, Vol.198, p.25-32

2018

Volltextzugriff (PDF)

Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers

Blood, 2009-02, Vol.113 (9), p.2064-2069

2009

Volltextzugriff (PDF)

Polymorphisms in the protein C gene as risk factor for venous thrombosis

Thrombosis and haemostasis, 2009-01, Vol.101 (1), p.62-67

2009

Volltextzugriff (PDF)

Prehospital paths and hospital arrival time of patients with acute coronary syndrome or stroke, a prospective observational study

BMC emergency medicine, 2016-01, Vol.16 (2), p.3-3, Article 3

2016

Volltextzugriff (PDF)

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

Heart and vessels, 2016-11, Vol.31 (11), p.1731-1739

2016

Volltextzugriff (PDF)

Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk

British journal of haematology, 2010-04, Vol.149 (1), p.118-123

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial

Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial

Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1

Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations

Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis

Travel-related venous thrombosis: results from a large population-based case control study (MEGA study)

Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Malignancies, prothrombotic mutations, and the risk of venous thrombosis

Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases

Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use

Plasma levels of fibrinolytic proteins and the risk of myocardial infarction in men

Enhancing discharge decision-making through continuous monitoring in an acute admission ward: a randomized controlled trial

Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial

ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men

Early cardiopulmonary resuscitation and use of Automated External Defibrillators by laypersons in out-of-hospital cardiac arrest using an SMS alert service

Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men

Alcohol consumption is associated with a decreased risk of venous thrombosis

Three‐year clinical outcome in all‐comers with “silent” diabetes, prediabetes, or normoglycemia, treated with contemporary coronary drug‐eluting stents: From the BIO‐RESORT Silent Diabetes study

Bioresorbable Polymer-Coated Orsiro Versus Durable Polymer-Coated Resolute Onyx Stents (BIONYX): Rationale and design of the randomized TWENTE IV multicenter trial

Effect of elevated levels of coagulation factors on the risk of venous thrombosis in long-distance travelers

Polymorphisms in the protein C gene as risk factor for venous thrombosis

Prehospital paths and hospital arrival time of patients with acute coronary syndrome or stroke, a prospective observational study

Long-term outcome and chest pain in patients with true versus non-true bifurcation lesions treated with second-generation drug-eluting stents in the TWENTE trial

Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk

Aktive Filter

Suchergebnisse filtern